Detalles de la búsqueda
1.
Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
J Infect Dis
; 225(6): 1091-1099, 2022 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32437567
2.
Recent developments in the regulation of cholesterol transport by natural molecules.
Phytother Res
; 35(10): 5623-5633, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34327759
3.
[Impact of the Timing of Traditional Chinese Medicine Therapy on the Therapeutic Effect and Prognosis of Severe Coronavirus Disease 2019].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 42(4): 521-530, 2020 Aug 30.
Artículo
en Zh
| MEDLINE | ID: mdl-32895105
4.
[Bioinformatic analysis of differentially expressed genes and immune cell infiltration in primary biliary cholangitis patients with poor response to ursodeoxycholic acid therapy].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
; 38(1): 16-23, 2022 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-35078571
5.
Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence.
Chin Med
; 17(1): 23, 2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35180857
6.
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial.
J Ethnopharmacol
; 293: 115210, 2022 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35398501
7.
High Expression of Ubiquitin-Specific Protease 39 and Its Roles in Prognosis in Patients with Hepatocellular Carcinoma.
Evid Based Complement Alternat Med
; 2021: 6233175, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34987596
Resultados
1 -
7
de 7
1
Próxima >
>>